company background image
MASS logo

908 Devices NasdaqGM:MASS Stock Report

Last Price

US$2.06

Market Cap

US$71.7m

7D

-1.0%

1Y

-77.9%

Updated

22 Dec, 2024

Data

Company Financials +

MASS Stock Overview

A commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. More details

MASS fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

908 Devices Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for 908 Devices
Historical stock prices
Current Share PriceUS$2.06
52 Week HighUS$12.51
52 Week LowUS$1.82
Beta0.91
1 Month Change-19.53%
3 Month Change-41.14%
1 Year Change-77.92%
3 Year Change-92.27%
5 Year Changen/a
Change since IPO-95.80%

Recent News & Updates

Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts

Nov 15
Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts

908 Devices: Key Investor Now Selling

Sep 08

Why We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge

Aug 16
Why We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge

Recent updates

Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts

Nov 15
Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts

908 Devices: Key Investor Now Selling

Sep 08

Why We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge

Aug 16
Why We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge

We Think 908 Devices (NASDAQ:MASS) Can Afford To Drive Business Growth

Mar 30
We Think 908 Devices (NASDAQ:MASS) Can Afford To Drive Business Growth

Investors Appear Satisfied With 908 Devices Inc.'s (NASDAQ:MASS) Prospects

Dec 18
Investors Appear Satisfied With 908 Devices Inc.'s (NASDAQ:MASS) Prospects

908 Devices Q2 2022 Earnings Preview

Aug 08

908 Devices Aims For Broadened Footprint

Feb 02

Shareholder Returns

MASSUS ElectronicUS Market
7D-1.0%-3.1%-2.4%
1Y-77.9%17.7%23.4%

Return vs Industry: MASS underperformed the US Electronic industry which returned 17.6% over the past year.

Return vs Market: MASS underperformed the US Market which returned 23.3% over the past year.

Price Volatility

Is MASS's price volatile compared to industry and market?
MASS volatility
MASS Average Weekly Movement12.3%
Electronic Industry Average Movement6.4%
Market Average Movement6.3%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: MASS's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: MASS's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2012230Kevin Knopp908devices.com

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis.

908 Devices Inc. Fundamentals Summary

How do 908 Devices's earnings and revenue compare to its market cap?
MASS fundamental statistics
Market capUS$71.74m
Earnings (TTM)-US$60.19m
Revenue (TTM)US$55.16m

1.3x

P/S Ratio

-1.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MASS income statement (TTM)
RevenueUS$55.16m
Cost of RevenueUS$27.13m
Gross ProfitUS$28.03m
Other ExpensesUS$88.22m
Earnings-US$60.19m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.73
Gross Margin50.81%
Net Profit Margin-109.11%
Debt/Equity Ratio0%

How did MASS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 05:38
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

908 Devices Inc. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Puneet SoudaLeerink Partners LLC
Jacob JohnsonStephens, Inc.
Daniel AriasStifel, Equities Research